Hypertension in Breast Cancer Patients Receiving Bevacizumab

Stopped early

Conditions studied: Breast Cancer

In brief

This research study will look at the effect of an anti-angiogenesis medication called Bevacizumab on blood vessels. Anti-angiogenesis medicines fight cancer by cutting off a tumor's blood supply, starving the tumor of nutrients and oxygen. Previous studies have shown these types of drugs can cause hypertension. The purpose of this study is to help researchers better understand why these drugs cause hypertension. This information will assist researchers in learning how to control this side effect.

Key facts

Study ID
NCT00674011
Run by
Dana-Farber Cancer Institute
People needed
10
Starts
2008-01-01
Expected to finish
2010-09-01
Last updated by the study team
2014-05-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.